What's new! CIDG publications January 2019

Details below on the latest submission to the Cochrane Database of Systematic Reviews Issue 1 2019 from the Cochrane Infectious Diseases Group (reviews and protocols published 1 – 31 January).

3 Updated reviews

Gonzales  MLM, Dans  LF, SioAguilar  J. Antiamoebic drugs for treating amoebic colitis. Cochrane Database of Systematic Reviews 2019, Issue 1. Art. No.: CD006085. DOI: 10.1002/14651858.CD006085.pub3 

Pryce  J, Hine  P. Pyronaridineartesunate for treating uncomplicated  Plasmodium falciparum malaria. Cochrane Database of Systematic Reviews 2019, Issue 1. Art. No.: CD006404. DOI: 10.1002/14651858.CD006404.pub3.  Read the LSTM news article

Macfarlane  CL, Budhathoki  SS, Johnson  S, Richardson  M, Garner  P. Albendazole alone or in combination with microfilaricidal drugs for lymphatic filariasis. Cochrane Database of Systematic Reviews 2019, Issue 1. Art. No.: CD003753. DOI: 10.1002/14651858.CD003753.pub4.

 

The CIDG editorial base is located at the Liverpool School of Tropical Medicine  in Liverpool, UK. The CIDG is led by Professor Paul Garner (Co-ordinating Editor) and Deirdre Walshe (Managing Editor). Over 600 authors from some 52 countries contribute to the preparation of the Cochrane Reviews. They are supported by an international team of Editors, each with topic or methodological expertise. 

The CIDG’s main areas of work are on determination of the effects of interventions on the prevention or treatment infectious diseases of relevance to the  United Nations Sustainable Development Goals, particularly malaria, tuberculosis, HIV/AIDS, and neglected tropical diseases. The aims of the CIDG are to impact on policy and research in tropical diseases through the production of high quality and relevant systematic reviews, and to lead developments in review quality improvement and effective dissemination of findings.